Antihemophilic Factor (Recombinant) (Afstyla) and Tafamidis, Tafamidis Meglumine
Determining the interaction of Antihemophilic Factor (Recombinant) (Afstyla) and Tafamidis, Tafamidis Meglumine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: tafamidis
Brand name: Vyndamax, Vyndaqel
Synonyms: Tafamidis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Afstyla)-Tafenoquine
- Antihemophilic Factor (Recombinant) (Afstyla)-Tafenoquine (Malaria Prevention)
- Antihemophilic Factor (Recombinant) (Afstyla)-Tafenoquine (Prevention of Malaria Relapse)
- Antihemophilic Factor (Recombinant) (Afstyla)-Tafenoquine Succinate (Arakoda)
- Antihemophilic Factor (Recombinant) (Afstyla)-Tafenoquine Succinate (Krintafel)
- Antihemophilic Factor (Recombinant) (Afstyla)-Tafinlar
- Tafamidis, Tafamidis Meglumine-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Tafamidis, Tafamidis Meglumine-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Tafamidis, Tafamidis Meglumine-Antihemophilic Factor (Recombinant) (Nuwiq)
- Tafamidis, Tafamidis Meglumine-Antihemophilic Factor (Recombinant) (Recombinate)
- Tafamidis, Tafamidis Meglumine-Antihemophilic Factor (Recombinant) (Xyntha)
- Tafamidis, Tafamidis Meglumine-Antihemophilic factor (recombinant) pegylated-aucl Intravenous